NO963540L - X-ray contrast compositions containing cellulose derivatives - Google Patents

X-ray contrast compositions containing cellulose derivatives

Info

Publication number
NO963540L
NO963540L NO963540A NO963540A NO963540L NO 963540 L NO963540 L NO 963540L NO 963540 A NO963540 A NO 963540A NO 963540 A NO963540 A NO 963540A NO 963540 L NO963540 L NO 963540L
Authority
NO
Norway
Prior art keywords
ray contrast
compositions containing
cellulose derivatives
containing cellulose
contrast compositions
Prior art date
Application number
NO963540A
Other languages
Norwegian (no)
Other versions
NO963540D0 (en
Inventor
Carl R Illig
John Toner
Edward James Baker
Robert Lee
Tom Caulfield
Brent D Douty
Kurt Josef
Edward R Bacon
Kimberly Estep
Saul Daum
Eugene R Cooper
Original Assignee
Nycomed Imaging As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/201,731 external-priority patent/US5422114A/en
Priority claimed from US08/206,552 external-priority patent/US5443814A/en
Priority claimed from US08/217,138 external-priority patent/US5385721A/en
Priority claimed from US07/216,988 external-priority patent/US5385720A/en
Priority claimed from US08/222,787 external-priority patent/US5466435A/en
Priority claimed from US08/227,422 external-priority patent/US5543132A/en
Priority claimed from US08/227,423 external-priority patent/US5368837A/en
Priority claimed from US08/227,415 external-priority patent/US5525327A/en
Priority claimed from US08/229,048 external-priority patent/US5385722A/en
Priority claimed from US08/246,888 external-priority patent/US5607660A/en
Publication of NO963540D0 publication Critical patent/NO963540D0/en
Application filed by Nycomed Imaging As filed Critical Nycomed Imaging As
Publication of NO963540L publication Critical patent/NO963540L/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A61K49/0404—X-ray contrast preparations containing barium sulfate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A61K49/0409—Physical forms of mixtures of two different X-ray contrast-enhancing agents, containing at least one X-ray contrast-enhancing agent which is not a halogenated organic compound
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A61K49/0433—X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A61K49/0433—X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
    • A61K49/0442—Polymeric X-ray contrast-enhancing agent comprising a halogenated group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A61K49/0433—X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
    • A61K49/0447—Physical forms of mixtures of two different X-ray contrast-enhancing agents, containing at least one X-ray contrast-enhancing agent which is a halogenated organic compound
    • A61K49/0461—Dispersions, colloids, emulsions or suspensions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A61K49/0433—X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
    • A61K49/0447—Physical forms of mixtures of two different X-ray contrast-enhancing agents, containing at least one X-ray contrast-enhancing agent which is a halogenated organic compound
    • A61K49/0495—Physical forms of mixtures of two different X-ray contrast-enhancing agents, containing at least one X-ray contrast-enhancing agent which is a halogenated organic compound intended for oral administration

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Dispersion Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicinal Preparation (AREA)

Abstract

Det beskrives en røntgenkontrastblanding for oral eller retrograd undersøkelse av det gastrointestinale system omfattende et rønt- genkontrastgivende middel i en farmasøytisk akseptabel bærer som omfatter et cellulose- derivat.An X-ray contrast composition is described for oral or retrograde examination of the gastrointestinal system comprising an X-ray contrast agent in a pharmaceutically acceptable carrier comprising a cellulose derivative.

NO963540A 1994-02-25 1996-08-23 X-ray contrast compositions containing cellulose derivatives NO963540L (en)

Applications Claiming Priority (10)

Application Number Priority Date Filing Date Title
US08/201,731 US5422114A (en) 1993-03-01 1994-02-25 Compositions of iodoaniline derivatives and cellulose derivatives for visualization of the gastrointestinal tract
US08/206,552 US5443814A (en) 1992-05-01 1994-03-04 X-ray contrast compositions containing iodophenoxyalkanes and cellulose derivatives
US08/217,138 US5385721A (en) 1993-02-04 1994-03-22 Compositions of alkylbenzenes and cellulose derivatives for visualization of the gastrointestinal tract
US07/216,988 US5385720A (en) 1993-03-11 1994-03-23 Compositions of iodobenzoic acid derivatives and cellulose derivatives for visualization of the gastrointestinal tract
US08/222,787 US5466435A (en) 1993-03-11 1994-04-04 Compositions of iodophenoxy alkylene ethers and cellulose derivatives for visualization of the gastrointestinal tract
US08/227,422 US5543132A (en) 1994-04-14 1994-04-14 X-ray contrast compositions containing a barium salt and a cellulose derivative
US08/227,423 US5368837A (en) 1994-04-14 1994-04-14 X-ray contrast compositions containing an organic crystalline X-ray contrast agent and a cellulose derivative
US08/227,415 US5525327A (en) 1994-04-14 1994-04-14 Polymeric x-ray contrast compositions containing iodinated polymeric beads and microcrystaline cellulose
US08/229,048 US5385722A (en) 1993-03-31 1994-04-18 Compositions of iodophenyl esters and iodophenyl sulfonates and cellulose derivatives for visualization of the gastrointestinal tract
US08/246,888 US5607660A (en) 1993-02-02 1994-05-20 Compositions of iodophenoxy alkanes and iodophenyl ethers in combination with cellulose derivatives for visualization of the gastrointestinal tract

Publications (2)

Publication Number Publication Date
NO963540D0 NO963540D0 (en) 1996-08-23
NO963540L true NO963540L (en) 1996-10-23

Family

ID=27581136

Family Applications (1)

Application Number Title Priority Date Filing Date
NO963540A NO963540L (en) 1994-02-25 1996-08-23 X-ray contrast compositions containing cellulose derivatives

Country Status (10)

Country Link
EP (1) EP0746339A1 (en)
JP (1) JPH09509424A (en)
CN (1) CN1146159A (en)
AU (1) AU1816395A (en)
CA (1) CA2184089A1 (en)
FI (1) FI963299A0 (en)
HU (1) HUT76336A (en)
MX (1) MX9603611A (en)
NO (1) NO963540L (en)
WO (1) WO1995022995A1 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9603547D0 (en) * 1996-02-20 1996-04-17 Nycomed Imaging As Contrast media
US7684852B2 (en) 2002-04-06 2010-03-23 Bracco Diagnostics Inc. System, formulation, kit and method for tagging colonic residue in an individual
EP2247314A4 (en) * 2008-02-01 2013-11-27 Univ Boston Cationic contrast agents and methods of use thereof
WO2014145509A1 (en) 2013-03-15 2014-09-18 The Regents Of The University Of California Enteric ct contrast material based on low-z atoms
WO2015024025A1 (en) 2013-08-16 2015-02-19 The Regents Of The University Of California Silicone-based enteric ct contrast material
US10918742B2 (en) * 2016-03-25 2021-02-16 Nanoprobes, Inc. Iodine-based particles
CN109540936A (en) * 2019-01-11 2019-03-29 大连大学附属中山医院 It is a kind of for high-resolution ct and the room temperature contrast agent of x-ray artery, vein or pipeline and preparation method thereof
CA3201017A1 (en) * 2020-12-28 2022-07-07 Boston Scientific Scimed, Inc. Polysaccharides having improved radiocontrast properties

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB767788A (en) * 1953-12-28 1957-02-06 Schering Corp Polyiodinated phenyl fatty acid compounds and process for their manufacture
CH338274A (en) * 1954-01-08 1959-05-15 Schering Corp Use as radiopaque agents of polyiodinated phenoxy fatty acids
CA985626A (en) * 1970-03-10 1976-03-16 E.R. Squibb And Sons Coating composition for moist surface
US4406878A (en) * 1978-08-02 1983-09-27 Eastman Kodak Company Iodinated contrast agent for radiography
CA2094893A1 (en) * 1992-05-01 1993-11-02 Carl R. Illig X-ray contrast compositions containing film-forming materials
US5342605A (en) * 1992-05-01 1994-08-30 Sterling Winthrop Inc. Polymeric X-ray compositions containing iodinated polymeric beads
US5260049A (en) * 1992-05-01 1993-11-09 Sterling Winthrop Inc. X-ray contrast compositions comprising alkoxyphenols
WO1994005336A1 (en) * 1992-09-01 1994-03-17 Sterling Wintrop Inc. Film-forming x-ray contrast compositions
NZ250063A (en) * 1992-12-14 1996-03-26 Eastman Kodak Co Iodinated aromatic acid ester derivatives; x-ray contrast compositions
US5322679A (en) * 1992-12-16 1994-06-21 Sterling Winthrop Inc. Iodinated aroyloxy esters
US5316755A (en) * 1993-02-02 1994-05-31 Sterling Winthrop Inc. Compositions of iodophenoxy alkanes and iodophenyl ethers for visualization of the gastrointestinal tract
US5326553A (en) * 1993-02-02 1994-07-05 Sterling Winthrop Inc. Compositions of iodophenoxy alkanes and iodophenyl ethers in film-forming materials for visualization of the gastrointestinal tract
US5334370A (en) * 1993-02-04 1994-08-02 Sterling Winthrop Inc. Compositions of alkylbenzenes in film-forming materials for visualization of the gastrointestinal tract
US5308607A (en) * 1993-02-04 1994-05-03 Sterling Winthrop Inc. Compositions of alkylbenzenes for visualization of the gastrointestinal tract using X-ray contrast
US5330740A (en) * 1993-03-01 1994-07-19 Sterling Winthrop Inc. Compositions of iodoaniline derivatives in film-forming materials for visualization of the gastrointestinal tract
US5310537A (en) * 1993-03-01 1994-05-10 Sterling Winthrop Inc. Compositions of iodoaniline derivatives for visualization of the gastrointestinal tract
US5310538A (en) * 1993-03-11 1994-05-10 Sterling Winthrop Inc. Compositions of iodophenoxy alkylene ethers in film-forming materials for visualization of the gastrointestinal tract
US5344638A (en) * 1993-03-11 1994-09-06 Sterling Winthrop Inc. Compositions of iodobenzoic acid derivatives for visualization of the gastrointestinal tract
US5312616A (en) * 1993-03-11 1994-05-17 Sterling Winthrop Inc. Compositions of iodobenzoic acid derivatives in film-forming materials for visualization of the gastrointestinal tract
US5318769A (en) * 1993-03-31 1994-06-07 Sterling Winthrop Inc. Compositions of iodophenyl esters for X-ray visualization of the gastrointestinal tract
US5336484A (en) * 1993-03-31 1994-08-09 Sterling Winthrop Inc. Compositions of iodophenyl esters and iodophenyl sulfonates in film-forming materials for visualization of the gastronintestinal tract

Also Published As

Publication number Publication date
FI963299A (en) 1996-08-23
EP0746339A1 (en) 1996-12-11
JPH09509424A (en) 1997-09-22
FI963299A0 (en) 1996-08-23
WO1995022995A1 (en) 1995-08-31
NO963540D0 (en) 1996-08-23
MX9603611A (en) 1997-04-30
CN1146159A (en) 1997-03-26
AU1816395A (en) 1995-09-11
HUT76336A (en) 1997-08-28
HU9602321D0 (en) 1996-10-28
CA2184089A1 (en) 1995-08-31

Similar Documents

Publication Publication Date Title
AR027162A1 (en) COMPOUNDS OF 2-PHENYL-3-PHENOXYL-PHENYLTIO-BENZOTIOFEN, PHARMACEUTICALLY ACCEPTABLE SALTS OF THE SAME AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
NO20016198D0 (en) Oral pharmaceutical compositions containing taxanes and methods of using the same in treatment
ES2037385T3 (en) A MANUFACTURING PROCEDURE OF A PHARMACEUTICAL PREPARATION FOR LOCAL ADMINISTRATION.
UY24555A1 (en) NEW COMPOUNDS
NO922026D0 (en) DELAYED RELEASE FORMULATIONS
EE04578B1 (en) Pharmaceutical composition for oral administration of the N-piperidino-3-pyrazolecarboxamide derivative, its salts and their solvates
ATE241990T1 (en) MEDICINAL COMPOSITIONS CONTAINING 3-BETA-HYDROXYLATED NATURAL STEROID DERIVATIVES AND THEIR USE
ATE310519T1 (en) MEDICINAL COMPOSITIONS CONTAINING ASCOMYCIN DERIVATIVES
NO933482L (en) N-sulfonyl-2-oxoindole derivatives having affinity for vasopressin and / or ocytocin receptors
CY1107909T1 (en) Multilayer disc containing rosiglitazone
NO963540L (en) X-ray contrast compositions containing cellulose derivatives
FI921525A (en) AMIDINOPHENYLALANATE DERIVATIVES
NO954287L (en) Use of indole derivatives as 5-HT1 agonists
MX9300628A (en) NEW DERIVATIVES OF TAXANE, PROCEDURE FOR ITS PREPARATION AND PHARMACEUTICAL COMPOSITION THAT CONTAINS THEM.
IL113365A (en) 5-Heterocyclo-1,5-benzodiazepine derivatives their preparation and pharmaceutical compositions containing them
NO964451L (en) X-ray contrast compositions containing pharmaceutically acceptable clays
ES2174113T3 (en) NEW DERIVATIVES OF ((3-ALCOXI-FENOXI) -ETIL) -DIALQUILAMINE AND ITS USE AS LOCAL ANESTHETICS.
MX9302501A (en) RADIOGRAPHIC CONTRAST COMPOSITIONS AND METHODS FOR USE IN VISUALIZATION OF INTESTINAL DUCT
HUT49876A (en) Process for producing 6-oxopyridazine derivatives and pharmaceutical compositions comprising same
MX9602407A (en) Pharmaceutical compositions.
MX9207162A (en) QUINOLINE DERIVATIVES, PROCEDURES FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM.
AU567498B2 (en) 5-phenyl-1h-2,3-dihydro-1,4-benzodiazepine derivatives.
AU4847390A (en) Fluorinated flavone acetic acid
ES2145541T3 (en) NEW SECO-D-STEROIDS ACTIVE ON THE CARDIOVASCULAR SYSTEM, PROCEDURES FOR ITS PREPARATION AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM.
DE69215511D1 (en) GEM-DIPHOSPHONIC ACID-NITROSOCARBAMOYL DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL PREPARATIONS CONTAINING THE SAME